Impact of a United Kingdom-wide campaign to tackle antimicrobial resistance on self-reported knowledge and behaviour change by Chaintarli, Katerina et al.
                          Chaintarli, K., Ingle, S. M., Bhattacharya, A., Ashiru-Oredope, D., Oliver, I.,
& Gobin, M. (2016). Impact of a United Kingdom-wide campaign to tackle
antimicrobial resistance on self-reported knowledge and behaviour change.
BMC Public Health, 16(393 ), [16]. DOI: 10.1186/s12889-016-3057-2
Publisher's PDF, also known as Version of record
License (if available):
CC BY
Link to published version (if available):
10.1186/s12889-016-3057-2
Link to publication record in Explore Bristol Research
PDF-document
This is the final published version of the article (version of record). It first appeared online via BioMed Central at
10.1186/s12889-016-3057-2. Please refer to any applicable terms of use of the publisher.
University of Bristol - Explore Bristol Research
General rights
This document is made available in accordance with publisher policies. Please cite only the published
version using the reference above. Full terms of use are available:
http://www.bristol.ac.uk/pure/about/ebr-terms.html
RESEARCH ARTICLE Open Access
Impact of a United Kingdom-wide
campaign to tackle antimicrobial resistance
on self-reported knowledge and behaviour
change
Katerina Chaintarli1,2*, Suzanne M. Ingle2, Alex Bhattacharya3, Diane Ashiru-Oredope3, Isabel Oliver1,2
and Maya Gobin1,2
Abstract
Background: As part of the 2014 European Antibiotic Awareness Day plans, a new campaign called Antibiotic
Guardian (AG) was launched in the United Kingdom, including an online pledge system to increase commitment
from healthcare professionals and members of the public to reduce antimicrobial resistance (AMR). The aim of this
evaluation was to determine the impact of the campaign on self-reported knowledge and behaviour around AMR.
Methods: An online survey was sent to 9016 Antibiotic Guardians (AGs) to assess changes in self-reported
knowledge and behaviour (outcomes) following the campaign. Logistic regression models, adjusted for variables
including age, sex and pledge group (pledging as member of public or as healthcare professional), were used to
estimate associations between outcomes and AG characteristics.
Results: 2478 AGs responded to the survey (27.5 % response rate) of whom 1696 (68.4 %) pledged as healthcare
professionals and 782 (31.6 %) as members of public (similar proportions to the total number of AGs). 96.3 % of all
AGs who responded had prior knowledge of AMR. 73.5 % of participants were female and participants were most
commonly between 45 and 54 years old.
Two thirds (63.4 %) of participants reported always acting according to their pledge. Members of the public were
more likely to act in line with their pledge than professionals (Odds Ratio (OR) =3.60, 95 % Confidence Interval (CI):
2.88-4.51). Approximately half of participants (44.5 %) (both healthcare professionals and members of public)
reported that they acquired more knowledge about AMR post-campaign. People that were confused about AMR
prior to the campaign acquired more knowledge after the campaign (OR = 3.10, 95 % CI: 1.36-7.09). More
participants reported a sense of personal responsibility towards tackling AMR post-campaign, increasing from
58.3 % of participants pre-campaign to 70.5 % post-campaign.
Conclusion: This study demonstrated that the campaign increased commitment to tackling AMR in both
healthcare professional and member of the public, increased self-reported knowledge and changed self-reported
behaviour particularly among people with prior AMR awareness. Online pledge schemes can be an effective and
inexpensive way to engage people with the problem of AMR especially among those with prior awareness of the
topic.
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Background
Antimicrobial resistance (AMR) is a major public health
problem and is partly associated with high levels of anti-
microbial use [1–3]. Prescribing practices in humans
and animals have led to the overuse and misuse of anti-
microbials and the development of AMR [4–7]. AMR
remains an important issue for the United Kingdom
(UK) despite a reduction in the total consumption of antibi-
otics in recent years [8, 9]. The World Health Organisation
(WHO) Global Strategy for Containment of Antimicrobial
Resistance provides a framework for interventions to slow
the emergence and reduce the spread of AMR [10, 11].
One aim of the strategy includes actions to educate mem-
bers of the public and healthcare professionals about
AMR [11]. Similarly in the UK, the 5 year UK AMR strat-
egy (2013) includes improving professional education,
training and public engagement as one of its seven key
areas [12].
Numerous educational campaigns have been imple-
mented worldwide to help tackle AMR with differing
levels of effectiveness [6, 13–21]. The “European Anti-
biotic Awareness Day” (EAAD) was initiated by the
European Centre for Disease Prevention and Control to
raise awareness towards antibiotic use [22, 23]. The UK
“Antibiotic Guardian Campaign” was launched in
September 2014 to increase public and healthcare pro-
fessionals engagement and change behaviour towards
the rising threat of AMR [24]. It was also developed as a
way to have, for the first time an ‘always on’ (available all
year round) campaign for AMR. The campaign com-
prised an online pledge system (http://antibioticguar-
dian.com/) and was available to everyone with access to
the internet. People could select a single pledge from a
list tailored for either members of the public or health
care professionals (the third group “student or educator”
was added in October 2015 - after the evaluation of the
campaign had started) (Additional file 1). Online pledges
were one of the recommended interventions from a re-
cent behavioural analysis that identified key behaviours
and drivers for antibiotic use in both the public and
healthcare professionals [25, 26]. The Antibiotic Guard-
ian pledges were subsequently designed to overcome
the intention – behaviour gap through the formation of
implementation intentions (or if – then plans) [27]. Imple-
mentation intention is a method of deciding in advance
when, where and how a person will act on particular ac-
tion to reach a particular goal or objective using If-then
approach - If X happens, then I will do Y. For example,
one of the Antibiotic Guardian pledges for members of
the public states: ‘For infections that our bodies are good
at fighting off on their own, like coughs, colds, sore
throats and flu, I pledge to talk to my pharmacist about
how to treat the symptoms first rather than going to the
GP’ and for a general practitioner (GP) one of the
pledges available to select from is ‘The next time I in-
tend to prescribe antibiotics for a self-limiting infection
to a patient with high expectations of antibiotic treat-
ment, I will use a delayed/backup prescription’. Using im-
plementation intentions have been shown through several
meta-analyses to support individuals as well as groups in
their intention-behaviour gaps [28, 29].
The initial concept for the website and logo was devel-
oped jointly with the British Society for Antimicrobial
Chemotherapy, who also kindly provided the initial
funding for the website. The campaign website was
launched by Public Health England (PHE) alongside the
release of digital resources such as posters, leaflets and
social media graphics developed at no additional cost by
PHE which were shared openly for use [30]. The AG
website included a video produced by PHE which edu-
cated on the threat of antimicrobial resistance and
linked to resources which described the importance of
AMR [23]. All materials were made available via the
English EAAD website and EAAD resources toolkit for
health care professionals [23]. PHE wrote letters to
leaders in primary and secondary care and professional
organisations with the purpose of forming a network
through which messages and materials could be pro-
moted and disseminated [31]. Further promotion for the
campaign by PHE took place at professional-facing con-
ferences through donated exhibition space. The 182 or-
ganisations that registered participation for EAAD by
30th November were also invited to promote the AG
campaign to staff and service users [23].
The main objective of that campaign was that by 30th
November 2014 at least 10,000 healthcare professionals
and members of the public would have committed to at
least one pledge for prudent use of antimicrobials. The
objective was met on the 19th November and by the end
of November there were 11,833 Antibiotic Guardians.
The aim of this evaluation was to determine whether
the AG campaign increased engagement and improved
AMR knowledge and behaviour.
Methods
An online questionnaire was developed to determine if
the campaign resulted in changes in self-reported know-
ledge/awareness and self-reported behaviour amongst
Antibiotic Guardians (AGs) (Additional file 2). AGs who
previously consented to follow up were sent the question-
naire via e-mail on 3rd February 2015, five months after
the launch of the campaign. The questionnaire was
available for completion for one month; a reminder
was sent via e-mail a week after the launch of the sur-
vey. Before launching the survey, the questionnaire
was reviewed by a wide range of healthcare profes-
sionals and members of the public who were members
of the EAAD planning group.
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Demographics of the pledge group (pledging as a
health professional or a member of the public), age, sex,
use of social media and whether working in a health re-
lated profession were collected (Questions 1–3 & 21–27).
Closed multi-choice questions were used to ascertain the
participant’s motivation for becoming an Antibiotic
Guardian and the reason for choosing their specific pledge
(Questions 4–6). Participants were asked to select the
options that best described their behaviour in relation
to the pledge (‘Pledge Behaviour’) and their general
knowledge/awareness of AMR before and after becom-
ing an Antibiotic Guardian (pre and post-campaign)
(Questions 7–14).
The perceived effectiveness of the promotion of the
campaign and quality of the promotional material were
ascertained through a series of multiple choice questions
(Questions 15–20). The questionnaire logic was de-
signed such that some questions were skipped depend-
ing on whether the participant had pledged as a member
of the public or as a healthcare professional.
The two primary outcomes “change in self-reported
behaviour” and “change in knowledge” were assessed
as the difference in reported frequency of pledge be-
haviour pre and post campaign and whether participants
stated a positive acquisition of knowledge post-campaign
respectively.
Statistical analysis
To assess bias in our sample, we compared the response
rates of members of public and health care professionals
among those who completed the survey with the total
population that signed up as an AG.
To assess the outcome ‘change in behaviour’ after the
campaign, we used an ordinal logistic regression model
[32] to estimate associations with the ordered categorical
outcome “acting in line with their pledge” (Question 7).
The model was adjusted for variables describing whether
participants acted according to their pledge before the
campaign and whether they remembered their pledge
(Questions 4 & 14). Multivariable analysis was con-
ducted taking into account pledge group, age and sex as
possible confounders.
To assess the outcome ‘knowledge of AMR after
the campaign’ we used a logistic regression model to
estimate associations with the outcome (Question
12). We looked for associations with knowledge be-
fore the campaign and whether people were confused
about what AMR is before the campaign (Questions
10 & 11). Multivariable analysis was conducted taking
into account pledge group, age and sex as possible
confounders.
For all categorical variables, the group with the largest
number of observations was used as the reference group
for each variable.
Missing values
After assessing the amount of missing data from our
models, we decided to perform some sensitivity analysis
to assess whether our complete-case study could be
biased. We assumed that data were missing at random,
although this cannot be tested [33]. A multiple imput-
ation model was developed using chained equations and
the ice command in Stata. The model included all the
covariates and outcomes of interest (as listed in Table 1)
as well as a comprehensive (but not exhaustive) list of
other variables collected. 20 imputed datasets were cre-
ated and were analysed following Rubin’s rules.
Data were analysed using Stata 13.1 [34].
Results
The questionnaire was completed by 2478 AGs; 27.5 %
(2478/9016) of those that consented for follow up and
received the questionnaire. Response rates in each
pledge group were similar (20.7 % for healthcare profes-
sionals and 21.5 % for members of the public). Table 1
shows the baseline characteristics of the 2478 AGs. Two
thirds of participants pledged as healthcare professionals
(68.4 %). Of those AGs with valid data, the majority were
females (73.5 %) and most participants were between 45
and 54 years old.
Of the 782 people who pledged as members of public,
134 (17.1 %) were healthcare professionals and 208
(26.6 %) were connected to the healthcare system (e.g.,
working in a healthcare organisation or health related
professional body). Characteristics of the survey partici-
pants were similar to those of the total population of
Antibiotic Guardians (Graph 1 shows job type for
healthcare professionals and certain job types/family sta-
tus for members of the public).
The majority of public participants (64.2 %) became
Antibiotic Guardians because they knew the importance
of antimicrobial resistance. For healthcare professionals
the reason most commonly stated was professional ex-
perience of AMR (32.5 %). For both healthcare profes-
sionals and members of public, the majority of
participants were able to remember their pledge either
in part (51.9 %) or completely (43.9 %). Also, for both
groups in total, most participants chose the specific
pledge because it was the one they could commit to
(57.5 %), or felt was most important (31.7 %). Almost all
participants of both groups (91.3 %) felt that the AG
campaign would contribute to the prevention of anti-
biotic resistance and they were part of a wider commu-
nity of people working to keep antibiotics active
(88.9 %).
Change in self-reported behaviour
Self-reported action in line with their pledge increased
from 30.7 % pre-campaign to 63.4 % post-campaign.
Chaintarli et al. BMC Public Health  (2016) 16:393 Page 3 of 9
Pledge group, pre-campaign reported pledge behaviour
and remembering the pledge were associated with post-
campaign reported pledge behaviour in the multivariable
analysis (Table 2). Members of the public were more
likely to report positive post-campaign pledge behaviour
(Adjusted Odds Ratio (aOR) = 3.60, 95 % Confidence
interval (CI): 2.88-4.51). Participants without positive
pre-campaign pledge behaviour were less likely to have
positive post-campaign pledge behaviour (aOR = 0.23,
95 % CI: 0.16-0.34). AGs who remembered the pledge
were more likely to have positive post-campaign behav-
iour (aOR = 1.96, 95 % CI: 1.63-2.36). Age and sex were
not associated with post-campaign pledge behaviour.
Members of the public stated that lack of opportunity
was the most common reason (60 %) for the absence of
Table 1 Baseline characteristics of survey participants, Number
of observations (N) = 2478
Variable N (%)
Pledge group
Healthcare Professionals 1696 (68.4 %)
Members of Public 782 (31.6 %)
Missing 0 (0 %)
Age
<35 years old 596 (24.1 %)
35-64 years old 1548 (62.5 %)
≥65 years old 114 (4.6 %)
Prefer not to say 10 (0.4 %)
Missing 210 (8.5 %)
Sex
Female 1657 (66.9 %)
Male 598 (24.1 %)
Prefer not to say 15 (0.6 %)
Missing 208 (8.4 %)
Do you remember your pledge?
Yes 1087 (43.9 %)
Somewhat 1286 (51.9 %)
No 105 (4.2 %)
Missing 0 (0 %)
Act in line with pledge before campaign
Strongly agree 761 (30.7 %)
Agree 1021 (41.2 %)
Tend to Agree 505 (20.4 %)
Tend to Disagree 101 (4.1 %)
Disagree 6 (0.2 %)
Strongly Disagree 4 (0.2 %)
Missing 80 (3.2 %)
Confusion on what AMR is before the campaign?
Yes 34 (1.4 %)
No 2399 (96.8 %)
Missing 45 (1.8 %)
Prior knowledge on AMR?
Yes 2386 (96.3 %)
No 44 (1.8 %)
Missing 48 (1.9 %)
Outcomes
Act in line with pledge after campaign
Always 1571 (63.4 %)
Most of the time 709 (28.6 %)
Some of the time 96 (3.9 %)
Occasionally 64 (2.6 %)
Never 37 (1.5 %)
Table 1 Baseline characteristics of survey participants, Number
of observations (N) = 2478 (Continued)
Missing 1 (0.0 %)
Acquired more knowledge of AMR after campaign
No 1316 (53.1 %)
Yes 1103 (44.5 %)
Missing 59 (2.4 %)
Table 2 Crude and Adjusted Odds Ratios from ordinal logistic
regression model for associations with Antibiotic Guardians
acting according to their pledge, N = 2242
Covariate N Crude OR
(95 % CI)
aOR
(95 % CI)
Act according to pledge
before becoming AG
Yes 2141 1.0 (ref) 1.0 (ref)
No 101 0.29 (0.20 – 0.43) 0.23 (0.16 – 0.34)
Remember the pledge
Completely 994 1.63 (1.37 – 1.95) 1.96 (1.63 – 2.36)
Somewhat 1163 1.0 (ref) 1.0 (ref)
No 85 0.28 (0.18 – 0.46) 0.24 (0.15 – 0.38)
Pledge group
Members of Public 708 3.09 (2.50 – 3.82) 3.60 (2.88 – 4.51)
Healthcare Professionals 1534 1.0 (ref) 1.0 (ref)
Age
<35 years old 592 0.94 (0.77 – 1.14) 0.86 (0.70 – 1.05)
35-64 years old 1530 1.0 (ref) 1.0 (ref)
≥65 years old 110 1.63 (1.04 – 2.54) 1.11 (0.68 – 1.79)
Prefer not to say 10 0.36 (0.11,1.16) 0.36 (0.10,1.24)
Sex
Female 1641 1.0 (ref) 1.0 (ref)
Male 591 0.99 (0.82 – 1.20) 1.09 (0.89 – 1.33)
Prefer not to say 10 2.03 (0.43-9.66) 3.92 (0.61-25.11)
N number of observations, OR odds ratio, aOR adjusted OR for all variables
listed in the table
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positive post-campaign pledge behaviour. For health pro-
fessionals, the expectations of others (mainly patients)
was the most common reason stated for not fulfilling
their pledge (40.4 %).
Knowledge/awareness of AMR
Approximately half of participants (44.5 %) (both health-
care professionals and members of public) reported that
they acquired more knowledge about AMR post-
campaign. More participants reported a sense of personal
responsibility towards tackling AMR post-campaign, in-
creasing from 58.3 % of participants pre-campaign to
70.5 % post-campaign. Of the participants who had not
acquired more knowledge post-campaign, the majority
(99.3 %) reported having good knowledge/awareness of
AMR pre-campaign.
Table 3 shows that participants were more likely to
have more knowledge about AMR post-campaign if they
did not have pre-campaign knowledge (aOR = 4.21, 95 %
CI: 2.04 – 8.67) or had some knowledge but were con-
fused about AMR (aOR =3.10, 95 % CI: 1.36 – 7.09).
Members of the public were less likely to have acquired
more knowledge post-campaign than healthcare profes-
sionals (aOR = 0.79, 95 % CI: 0.66 – 0.96). Age and sex
were not associated with the acquisition of more know-
ledge post-campaign.
Promotion
Over half of the participants for both healthcare profes-
sionals and members of public (61.7 %) thought the AG
campaign was well promoted in terms of motivating
them to take the pledge although more than half of them
(60.6 %) had not seen some of the promotional materials
such as the quiz or the crosswords. A greater proportion
of members of the public had not seen the different pro-
motional materials (43.2 %) as compared with healthcare
professionals (33.9 %), possibly because the campaign
was mainly promoted through healthcare settings. The
majority of participants said they were or would be will-
ing to actively promote the campaign to friends, family
and colleagues.
Overall participants stated that information from a
combination of sources influenced their decision to be-
come AGs. Table 4 shows that age was associated with
the type of information source with biggest impact (Chi2
tests P <0.001). Under 18 year olds were most influenced
by social media and the website whereas older partici-
pants were most influenced by colleagues or a combin-
ation of resources.
Missing data analysis
Looking at the pattern of missing data, 89 % of the re-
cords have complete data on the variables of interest.
The analysis was rerun using the imputed data and the
results were compared to the results of the original data-
set and were found to be similar.
Discussion
The AG campaign is the first published example of the
use of an online pledge system to improve AMR related
knowledge and behaviour amongst healthcare profes-
sionals and the general public. Our evaluation found that
the AG campaign contributed to an overall increase in
the personal commitment of healthcare professionals
and members of the public to tackle AMR as well as im-
proved self-reported AMR related behaviour and know-
ledge in both healthcare professionals and the general
public who participated in the campaign.
There was a difference in the level of reported change
in behaviour observed between healthcare professionals
and members of the public. Healthcare professionals
were less likely to act according to their pledge than
members of the public. Literature shows that healthcare
professionals’ perceptions about patient and professional
expectations continue to influence their AMR related
behaviour [35–38]. The last is also reflected by the
results of our survey where the expectations of others
was the most common reason stated among healthcare
Table 3 Crude and Adjusted Odd Ratios from logistic
regression model for associations with knowledge on
antimicrobial resistance after the Antibiotic Guardian campaign,
N = 2224
Covariate N Crude OR
(95 % CI)
aOR
(95 % CI)
Confused about AMR before
the campaign
Yes 29 3.21 (1.41 – 7.27) 3.10 (1.36 – 7.09)
No 2195 1.0 (ref) 1.0 (ref)
Prior knowledge on AMR
Yes 2182 1.0 (ref) 1.0 (ref)
No 42 3.95 (1.93 – 8.07) 4.21 (2.04 – 8.67)
Pledge group
Members of Public 700 0.83 (0.70 – 1.00) 0.79 (0.66 – 0.96)
Healthcare Professionals 1524 1.0 (ref) 1.0 (ref)
Age
<35 years old 585 1.13 (0.93 – 1.36) 1.12 (0.93 – 1.36)
35-64 years old 1521 1.0 (ref) 1.0 (ref)
≥65 years old 108 0.78 (0.52 – 1.16) 0.88 (0.58 – 1.33)
Prefer not to say 10 0.82 (0.23-2.91) 1.13 (0.29-4.41)
Sex
Female 1629 1.0 (ref) 1.0 (ref)
Male 585 0.92 (0.76 – 1.11) 0.89 (0.73 – 1.08)
Prefer not to say 10 0.29 (0.06-1.38) 0.29 (0.06-1.43)
N number of observations, OR odds ratio, aOR adjusted OR for all variables
listed in the table
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professionals for not fulfilling their pledge. A recom-
mendation for next campaigns would be to work with
the relevant groups to ensure that the pledges are
achievable and realistic.
Strengths and weaknesses of the campaign
The evaluation was conducted five months after the AG
campaign and only provides an assessment of the short
term impact of the campaign on self-reported behaviour.
The campaign did not include reminding the AGs of
their pledge and whilst a high proportion could remem-
ber their pledge in part less than half of the participants
could remember their pledge completely. The launch of
the AG campaign in the UK deliberately coincided with
the 2014 European Antibiotic Awareness Day (EAAD)
to move from awareness raising to increasing engage-
ment and commitment and to provide an ‘always on’
AMR campaign that was available all year round. As part
of the EAAD, European countries are provided with re-
sources to inform people about AMR and on the pru-
dent use of antibiotics although these resources were
published later than the AG campaign.
We found the campaign contributed to increasing the
personal commitment of healthcare professionals and
members of the public as well as improvement in self-
reported knowledge and awareness of AMR and was
particularly effective for people who were previously
confused about the subject. In general participants felt
that the AG campaign was well promoted, however, our
evaluation suggests that the campaign was less success-
ful in engaging people without previous professional or
personal experience of antimicrobial resistance. This
likely to be due to the routes of promoting the campaign
which relied on health and professional organisations ra-
ther than a public facing campaign using, for example,
mass media.
The AGs who responded to the survey were similar in
terms of pledge group to the total AG population. The
current evaluation indicated that a pledge scheme can
be an inexpensive and effective way of promoting know-
ledge, raising awareness and changing self-reporting be-
haviour on important public health issues especially
among people with prior awareness of the topic.
However, certain caveats should be considered when
reviewing the results. The majority of participants were
female and aged between 44 and 54 years old, two
demographic groups shown to be associated with better
AMR related knowledge and behaviour [39, 40]. Details
of the age and sex distribution of AGs were not available
and comparison with the survey participants was not
possible and non-responder bias cannot be excluded.
However, it is known that there is a greater proportion
of women between 35 and 54 years old among health-
care professionals [41, 42]. It is important for the next
campaign to identify ways of engaging men and people
of older age groups more effectively.
The evaluation was based on self-reported changes in
behaviour and knowledge. It is possible that acquies-
cence bias was present as participants would have been
aware of the desirability of a positive change in behav-
iour and knowledge around AMR. Recall bias may be
considered but the majority of participants were able to
remember their pledge either in part or completely five
months after taking their pledge.
The online questionnaire used for our evaluation was a
convenient and inexpensive way to quickly communicate
Table 4 Sources that made the biggest impact on becoming an Antibiotic Guardian in relation to age and use of social media
Sources that made the biggest impact on becoming an Antibiotic Guardian (%)
Printed materials YouTube Social media Website Colleagues Friends Combination None
Age
12-17 years old 0.0 0.0 28.6 28.6 0.0 28.6 14.3 0.0
18-24 years old 4.6 2.0 12.4 17.7 22.2 5.2 30.7 5.2
25-34 years old 4.6 2.3 16.2 15.2 26.6 2.8 21.3 11.1
35-44 years old 3.8 1.4 17.1 15.1 21.7 1.4 28.2 11.3
45-54 years old 4.9 1.3 8.6 18.7 20.2 1.6 33.9 10.8
55-64 years old 8.4 0.3 7.1 17.9 17.1 1.9 36.3 11.1
65-74 years old 13.9 1.0 8.9 17.8 8.9 5.0 24.8 19.8
75 years or older 15.4 0.0 0.0 7.7 7.7 7.7 46.2 15.4
Total 5.6 1.4 12.2 16.9 20.8 2.4 29.8 11.1
Social Media User
Yes 4.5 1.5 15.5 15.9 19.8 2.6 29.9 10.2
No 9.3 1.0 0.2 19.9 23.6 1.8 29.5 14.8
Total 5.6 1.4 12.1 16.8 20.7 2.4 29.9 11.3
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with a large number of AGs but risks a lower response
rate [43]. In addition, people who may have limited access
to internet such as those from older age groups may be
under-represented in such surveys. Other approaches may
be needed to have an impact on those with limited inter-
net access.
Overall, the survey was well completed; however,
there was some missing information in questions per-
taining to the promotion of the AG campaign and
demographic characteristics of the participants. We
have no reason to believe that these data are not miss-
ing at random (i.e., that men are less likely to answer
the gender question) although this cannot be formally
tested. Therefore, we imputed the missing data to re-
duce the chance of bias and improve power [33]. Ana-
lyses on the imputed data showed similar results to
those reported here. In the paper, only the analysis of
original data is reported.
Our evaluation provides the baseline characteristics
of the participants and a high level assessment of the
promotion of the campaign and impact on behaviour
and knowledge. Qualitative methods will be applied to
further investigate the results from the quantitative
analysis.
Context
The discovery of new antibiotics has proved challenging
[3] and a variety of different campaigns to help tackle
AMR have previously been developed; however a recent
summary of the campaigns in the UK highlight that al-
though the campaigns have increased awareness, there
has been limited impact on increasing knowledge and
changing behaviour [13]. Multifaceted educational pro-
grammes and antimicrobial stewardship interventions
targeting healthcare professionals are associated with
improved antimicrobial use [44, 45]. Mass media inter-
ventions as part of a multimodal campaign can also
play an important role in educating healthcare profes-
sionals and especially members of public about AMR
[13, 21, 45–48]. The AG campaign is the first published
example of the use of a pledge system to engage, edu-
cate and encourage others towards positive behaviour
change with regards to antibiotic prescribing, expect-
ation and use [24].
Pledges have been used in a number of different con-
texts to effect behaviour change at an individual and
organisational level [49–53]. Pledges are employed pri-
marily for four purposes: increase awareness, change
behaviour, engage others and collect data on individ-
uals [54]. Only a limited number of pledge schemes
have been evaluated and the evidence of effectiveness
of pledge schemes is inconsistent [54].
Factors that contribute to successful behaviour change
include direct personal contact with pledgees and prior
awareness of/engagement with the topic and reflect the
findings from our evaluation [54]. Although the majority
of participants could remember the general meaning of
their chosen pledge, over half could not remember in
full their pledge at five months. The last indicates the
need for regular communication with pledgees via e-
mails or newsletters to remind them of their pledge
and provide information on the topic. We also found
that the campaign was primarily adopted by people
with prior awareness of the topic which suggests that
similar pledge-based campaigns may not be the most
appropriate intervention to engage people with no
prior awareness. Identifying alternative promotional
methods to reach members of the public would be an
important next step for the campaign.
Any new or ongoing pledge campaigns should adopt
the lessons learnt from our evaluation and the tech-
niques that have been successfully implemented in
other similar campaigns [55, 56]. These include allow-
ing pledgees to create personalised pledges and getting
individuals to make pledges in public [57, 58]. Finally
our evaluation was developed after the campaign was
delivered and we recommend that evaluations be built
into the design of future campaigns to effectively cap-
ture pre and post-campaign effects on behaviour and
knowledge [13]. The next goal for the AG campaign
2015 is to have 100,000 Antibiotic Guardians by the
end of March 2016 and subsequently to assess the im-
pact of the campaign on outcomes such as reduced
antibiotic use or prescribing.
Conclusions
In conclusion, although there are limitations, we found
that the Antibiotic Guardian campaign was effective in
demonstrating engagement from healthcare profes-
sionals and members of the public to tackle antimicro-
bial resistance and also highlighted an increase in self-
reported commitment of healthcare professionals and
members of the public in their personal actions to
tackle antimicrobial resistance. It was also effective for
achieving positive changes in self-reported knowledge
and behaviour amongst people with prior awareness of
the topic. This approach could be developed further to
engage with other groups including those without prior
knowledge of AMR.
Ethics
The project was a service evaluation of intervention and
no ethics approval was required.
Availability of supporting data
Data can be requested through Public Health England.
Chaintarli et al. BMC Public Health  (2016) 16:393 Page 7 of 9
Additional files
Additional file 1: Table S1. Antibiotic Guardian pledges by target
audiences. (PDF 166 kb)
Additional file 2: Online questionnaire used for the evaluation of the
Antibiotic Guardian Campaign. (PDF 423 kb)
Abbreviations
AG: antibiotic guardian; AMR: antimicrobial resistance; aOR: adjusted odds
ratio; CI: confidence interval; EAAD: European Antibiotic Awareness Day;
OR: odds ratio; UK: United Kingdom; WHO: World Health Organisation.
Competing interests
KC, MG and IO worked/work for Public Health England (PHE). DAO and AB
were part of the PHE group that developed the Antibiotic Guardian
Campaign. SI is part of the Health Protection Research Unit at University of
Bristol funded by PHE.
Authors’ contributions
All authors have made substantial contributions to conception and design of
the study and have been involved in revising the manuscript critically for
important intellectual content. In addition, KC led the development of the
questionnaire, the collection, analysis and interpretation of data and the
drafting of the manuscript under the supervision of MG. SI contributed,
additionally, in the statistical analysis, interpretation of the results and
revision of the manuscript. DAO made significant contribution to the
conception of the study, development of the questionnaire and writing of
the manuscript. IO and AB contributed to the design of the study and have
been involved in revising the manuscript critically. All authors have read and
approved the manuscript, and have given final approval for submission.
Acknowledgements
We acknowledge the support of Dr Jo Kesten from the School of Social and
Community Medicine of University of Bristol and Anna Sallis CPsycol from
the Behaviour Insights team of Public Health England for their input; as well
as the EAAD/AG planning group for their feedback on the study
questionnaire. The study was partly supported by the NIHR Health Protection
Research Unit in Evaluation of Interventions at University of Bristol. The views
expressed are those of the author(s) and not necessarily those of the NHS,
the NIHR, the Department of Health or Public Health England.
Funding
The evaluation of the campaign was funded by the National Institute for
Health Research through the Health Protection Research Unit in Evaluation
of Interventions at University of Bristol.
Author details
1Field Epidemiology Service, Public Health England, Bristol, UK. 2Health
Protection Research Unit in Evaluation of Interventions, School of Social and
Community Medicine, University of Bristol, Bristol, UK. 3Antimicrobial
Resistance Programme, Public Health England, London, UK.
Received: 20 January 2016 Accepted: 29 April 2016
References
1. Goossens H, Ferech M, Vander SR, Elseviers M, Project E. Outpatient
antibiotic use in Europe and association with resistance : a cross-national
database study. Lancet. 2005;365:579–87.
2. Lipsitch M, Samore MH. Antimicrobial use and antimicrobial resistance: a
population perspective. Emerg Infect Dis. 2002;8(4):347–54.
3. Livermore DM. Discovery research: the scientific challenge of finding new
antibiotics. J Antimicrob Chemother. 2011;66(9):1941–4. [cited 2015 Jun 30]:
Available from: http://www.ncbi.nlm.nih.gov/pubmed/21700626.
4. Grigoryan L, Burgerhof JGM, Degener JE, Deschepper R, Lundborg CS,
Monnet DL, et al. Determinants of self-medication with antibiotics in
Europe: the impact of beliefs, country wealth and the healthcare system.
J Antimicrob Chemother. 2008;61(5):1172–9. [cited 2015 Jun 8]: Available
from: http://www.ncbi.nlm.nih.gov/pubmed/18296694.
5. Hunter PA, Dawson S, French GL, Goossens H, Hawkey PM, Kuijper EJ, et al.
Antimicrobial-resistant pathogens in animals and man: prescribing, practices
and policies. J Antimicrob Chemother. 2010;65(Supplement 1):i3–17. [cited
2015 Jun 30]: Available from: http://www.jac.oxfordjournals.org/cgi/doi/10.
1093/jac/dkp433.
6. Huttner B, Goossens H, Verheij T, Harbarth S. Characteristics and outcomes
of public campaigns aimed at improving the use of antibiotics in
outpatients in high-income countries. Lancet Infect Dis. 2010;10(1):17–31.
[cited 2015 Jun 3]: Elsevier Ltd; Available from: http://www.ncbi.nlm.nih.gov/
pubmed/20129146.
7. Plachouras D, Kavatha D, Antoniadou A, Giannitsioti E, Poulakou G,
Kanellakopoulou K, et al. Dispensing of antibiotics without prescription in
Greece, 2008: another link in the antibiotic resistance chain.
Eurosurveillance. 2010;15(7):4–7.
8. Fleming DM, Ross AM, Cross KW, Kendall H. The reducing incidence of
respiratory tract infection and its relation to antibiotic prescribing. Br J Gen
Pract. 2003;2000(October):778–83.
9. Public Health England. English surveillance programme for antimicrobial
utilisation and resistance (ESPAUR) Report 2014 About Public Health
England [Internet]. 2014. Available from: https://www.gov.uk/government/
uploads/system/uploads/attachment_data/file/362374/ESPAUR_Report_
2014__3_.pdf
10. Shallcross LJ, Davies SC. The World Health Assembly resolution on
antimicrobial resistance. J Antimicrob Chemother. 2014;69(11):2883–5. [cited
2015 Jun 12]: Available from: http://www.ncbi.nlm.nih.gov/pubmed/25204342.
11. WHO. WHO Global Strategy for Containment of Antimicrobial Strategy for
Containment of Antimicrobial Resistance [Internet]. 2001. Available from:
http://www.who.int/drugresistance/WHO_Global_Strategy_English.pdf
12. Public Health England. UK Five Year Antimicrobial Resistance Strategy 2013
to 2018 [Internet]. 2013. Available from: https://www.gov.uk/government/
uploads/system/uploads/attachment_data/file/244058/20130902_UK_5_
year_AMR_strategy.pdf
13. Ashiru-Oredope D, Hopkins S. Antimicrobial resistance : moving from
professional engagement to public action. J Antimicrob Chemother.
2015;7–10. doi:10.1093/jac/dkv297.
14. Chazan B, Ben R, Turjeman Z, Frost Y, Besharat B, Tabenkin H, et al.
Antibiotic consumption successfully reduced by a community intervention
program. IMAJ. 2007;9(January):16–20.
15. Formoso G, Paltrinieri B, Maria A, Gagliotti C, Pan A, Luisa M.
Feasibility and effectiveness of a low cost campaign on antibiotic
prescribing in Italy: community level, controlled, non-randomised trial.
BMJ. 2013;5391(September):1–10.
16. Kardas-Sloma L, Boëlle P-Y, Opatowski L, Guillemot D, Temime L. Antibiotic
reduction campaigns do not necessarily decrease bacterial resistance: the
example of methicillin-resistant Staphylococcus aureus. Antimicrob Agents
Chemother. 2013;57(9):4410–6. [cited 2015 Jun 12]: Available from:
http://www.pubmedcentral.nih.gov/articlerender.
fcgi?artid=3754303&tool=pmcentrez&rendertype=abstract.
17. Lambert MF, Masters GA, Brent SL. Can mass media campaigns change
antimicrobial prescribing? A regional evaluation study. J Antimicrob
Chemother. 2007;59(3):537–43. [cited 2015 Jun 12]: Available from:
http://www.ncbi.nlm.nih.gov/pubmed/17283035.
18. Mcnulty CAM, Boyle P, Nichols T, Clappison P, Davey P, Centre HI, et al. The
public’ s attitudes to and compliance with antibiotics. J Antimicrob
Chemother. 2007;60 (suppl 1):i63-i68. doi:10.1093/jac/dkm161.
19. Mcnulty CAM, Nichols T, Boyle PJ, Woodhead M, Davey P. The English
antibiotic awareness campaigns: did they change the public’s knowledge of
and attitudes to antibiotic use? J Antimicrob Chemother. 2010;65(7):1526-33.
doi:10.1093/jac/dkq126. First published online: May 20, 2010.
20. Plachouras D, Antoniadou A, Giannitsioti E, Galani L, Katsarolis I, Kavatha D,
et al. Promoting prudent use of antibiotics: the experience from a
multifaceted regional campaign in Greece. BMC Public Health. 2014.
21. Sabuncu E, David J, Bernède-Bauduin C, Pépin S, Leroy M, Boëlle P-Y, et al.
Significant reduction of antibiotic use in the community after a nationwide
campaign in France, 2002–2007. PLoS Med. 2009;6(6):e1000084. [cited 2014
Dec 2]: Available from: http://www.pubmedcentral.nih.gov/articlerender.
fcgi?artid=2683932&tool=pmcentrez&rendertype=abstract.
22. Dryden M, Johnson AP, Ashiru-Oredope D, Sharland M. Using antibiotics
responsibly: right drug, right time, right dose, right duration. J Antimicrob
Chemother. 2011;66(11):2441–3. [cited 2015 Jun 12]: Available from:
http://www.ncbi.nlm.nih.gov/pubmed/21926080.
Chaintarli et al. BMC Public Health  (2016) 16:393 Page 8 of 9
23. Earnshaw S, Monnet DL, Duncan B, O’Toole J, Ekdahl K, Goossens H, et al.
European Antibiotic Awareness Day, 2008 – The first Europe - wide public
information campaign on prudent antibiotic use: Methods and survey of
activities in participating countries. Eurosurveillance. 2008;14(30):1–8.
24. Ashiru-Oredope D, Hopkins S. Antimicrobial resistance: moving from
professional engagement to public action. J Antimicrob Chemother
[Internet]. 2015 Sep 16; Available from: http://jac.oxfordjournals.org/content/
early/2015/09/15/jac.dkv297.abstract
25. Public Health England. Behaviour change and antibiotic prescribing in
healthcare settings Literature review and behavioural analysis About Public
Health England About the Department of Health [Internet]. 2015. Available
from: https://www.gov.uk/government/uploads/system/uploads/
attachment_data/file/405031/Behaviour_Change_for_Antibiotic_
Prescribing_-_FINAL.pdf
26. Tonkin-crine S, Walker AS, Butler CC. Contribution of behavioural science to
antibiotic. BMJ. 2015;350:h3413.
27. Gollwitzer PM. Implementation Intentions. 1999;54(7):493–503.
28. Rhodes R, Dickau L. Experimental evidence for the intention-behavior
relationship in the physical activity domain: a meta-analysis. Heal Psychol.
2012;31(6):724–7.
29. Cooke R, Sheeran P. Moderation of cognition-intention and cognition-behaviour
relations: a meta-analysis of properties of variables from the theory of planned
behaviour. Br J Soc Psychol. 2004;43(2):159–86.
30. Public Health England. Antibiotic awareness resources: 2015 [Internet].
2015. Available from: https://www.gov.uk/government/collections/
european-antibiotic-awareness-day-resources
31. Public Health England. European Antibiotic Awareness Day: letters to NHS,
local authority and professional organisations [Internet]. 2015. Available
from: https://www.gov.uk/government/publications/european-antibiotic-
awareness-day-letters-to-nhs-and-local-authority-health-and-wellbeing-
boards
32. Armstrong BG, Sloan M. Ordinal regression models for epidemiologic data.
Am J Epidemiol. 1989;129(1):191–204.
33. Sterne JAC, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, et al.
Multiple imputation for missing data in epidemiological and clinical
research: potential and pitfalls. BMJ. 2009.
34. StataCorp. Stata Statistical Software: Release 13. College Station TSL. TX:
StataCorp LP; 2013.
35. Calbo E, Alvarez-Rocha L, Gudiol F, Pasquau J. A review of the factors
influencing antimicrobial prescribing. Enferm Infecc Microbiol Clin. 2013;31
Suppl 4:12–5. [cited 2015 Jul 27]: Available from: http://www.sciencedirect.
com/science/article/pii/S0213005X13701277.
36. Dempsey PP, Businger AC, Whaley LE, Gagne JJ, Linder JA. Primary care
clinicians’ perceptions about antibiotic prescribing for acute bronchitis: a
qualitative study. BMC Fam Pract. 2014;15:194. [cited 2015 Sep 2]: Available
from: http://www.pubmedcentral.nih.gov/articlerender.
fcgi?artid=4275949&tool=pmcentrez&rendertype=abstract.
37. Karras DJ, Ong S, Moran GJ, Nakase J, Kuehnert MJ, Jarvis WR, et al.
Antibiotic use for emergency department patients with acute diarrhea. Ann
Emerg Med. 2003;42(6):835–42. [cited 2015 Jul 27]: Available from:
http://www.sciencedirect.com/science/article/pii/S0196064403006024.
38. Paredes P, de la Peña M, Flores-Guerra E, Diaz J, Trostle J. Factors
influencing physicians’ prescribing behaviour in the treatment of childhood
diarrhoea: Knowledge may not be the clue. Soc Sci Med. 1996;42(8):1141–53.
[cited 2015 Jul 27]: Available from: http://www.sciencedirect.com/science/
article/pii/0277953695003878.
39. McNulty CAM, Boyle P, Nichols T, Clappison P, Davey P. Don’t wear me
out–the public's knowledge of and attitudes to antibiotic use. J Antimicrob
Chemother. 2007;59(4):727–38. [cited 2015 Sep 2]: Available from:
http://www.ncbi.nlm.nih.gov/pubmed/17307770.
40. You JHS, Yau B, Choi KC, Chau CTS, Huang QR, Lee SS. Public knowledge,
attitudes and behavior on antibiotic use: a telephone survey in Hong Kong.
Springer Link. 2008;36(2):153–7.
41. Yar M, Dix D, Bajekal M. Socio-demographic characteristics of the healthcare
workforce in England and Wales– results from the 2001 Census. Health Stat Q.
2006;32:44–56. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17165469.
42. WHO. Spotlight on statistics [Internet]. 2008. Available from: http://www.who.
int/hrh/statistics/spotlight_2.pdf?ua=1
43. Hunter L. Challenging the reported disadvantages of e-questionnaires and
addressing methodological issues of online data collection. Nurse Res.
2012;20(1):11–20.
44. Butler CC, Simpson SA, Evans J, Moore L. Effectiveness of multifaceted
educational programme to reduce antibiotic dispensing in primary care:
practice based randomised controlled trial. BMJ. 2012;8173(63355948):1–13.
45. Kaki R, Elligsen M, Walker S, Simor A, Palmay L, Daneman N. Impact of
antimicrobial stewardship in critical care: a systematic review. J Antimicrob
Chemother. 2011;66(6):1223–30. [cited 2015 Jun 30]: Available from:
http://www.jac.oxfordjournals.org/cgi/doi/10.1093/jac/dkr137.
46. Bauraind I, Lopez-Lozano J-M, Beyaert A, Marchal J-L, Seys B, Yane F, et al.
Association between antibiotic sales and public campaigns for their
appropriate use. JAMA. 2004;292(20):2465–70.
47. Campaign L, Locaal A. Doctors and local media: a synergy for public health
information?: a controlled trial to evaluate the effects of a multifaceted
campaign on antibiotic prescribing (protocol). BMC Public Health.
2011;11(1):816. [cited 2015 Jun 12]: BioMed Central Ltd; Available from:
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3212824&
tool=pmcentrez&rendertype=abstract.
48. Goossens H, Guillemot D, Ferech M, Schlemmer B, Costers M, van Breda M,
et al. National campaigns to improve antibiotic use. Eur J Clin Pharmacol.
2006;62(5):373–9.
49. Donovan RJ, Fisher DA, Armstrong BK. “Give it away for a day”: An
evaluation of Western Australia’s first smoke free day. Community Health
Stud. 2010;8(3):301–6.
50. Heiskanena E, Johnson M, Robinsonb S, Vadovicsc E, Saastamoinena M.
Low-carbon communities as a context for individual behavioural change.
Energy Policy. 2010;38(12):7586–95.
51. Hillier FC, Batterham AM, Nixon CA, Crayton AM, Pedley CL, Summerbell CD.
A community-based health promotion intervention using brief negotiation
techniques and a pledge on dietary intake, physical activity levels and
weight outcomes: lessons learnt from an exploratory trial. Public Health
Nutr. 2011;15(8):1446–55.
52. Petticrew M, Eastmure E, Mays N, Knai C, Durand MA, Nolte E. The public
health responsibility deal: how should such a complex public health policy
be evaluated ? J Public Health (Bangkok). 2013;35(4):495–501.
53. Raju S, Rajagopal P, Gilbride TJ. Marketing healthful eating to children:
the effectiveness of incentives, pledges, and competitions. J Mark.
2010;74(3):93–106.
54. Cotterill S, John P, Richardson L. Pledge campaigns to encourage charitable
giving: a randomised controlled trial [Internet]. Political Studies Association.
2010. Available from: https://www.researchgate.net/profile/Peter_John4/
publication/228979043_Pledge_campaigns_to_encourage_charitable_
giving_a_randomised_controlled_trial/links/02e7e517aac28a66f7000000.pdf
55. Edgar T, Boyd SD, Palamé MJ. Sustainability for behaviour change in the
fight against antibiotic resistance: a social marketing framework. J
Antimicrob Chemother. 2009;63(2):230–7. [cited 2015 Jul 13]. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/19095680.
56. Davey P, Garner S. Professional education on antimicrobial prescribing: a
report from the Specialist Advisory Committee on Antimicrobial Resistance
(SACAR) Professional Education Subgroup. J Antimicrob Chemother. 2007;60
Suppl 1:27–32. [cited 2015 Jun 30]. Available from: http://www.ncbi.nlm.nih.
gov/pubmed/17656378.
57. Cotterill S, Richardson L. Can pledging increase civic activity? A literature
review on developing community Pledgebanks [Internet]. 2009. Available
from: https://www.escholar.manchester.ac.uk/api/datastream?publication
Pid=uk-ac-man-scw:66966&datastreamId=FULL-TEXT.PDF
58. Burgess D, Haney B, Snyder M, Sullivan J, Transue J. Rocking the vote: using
personalized messages to motivate voting among young adults. Public
Opin Q. 2000;64(1):29–52.
Chaintarli et al. BMC Public Health  (2016) 16:393 Page 9 of 9
